13th World Congress in Fetal Medicine
Abstracts
 
  • Aneuploidies
  • cfDNA analysis of maternal blood
  • Fetal defect
    • Brain
    • Spine
    • Face
    • Heart
    • Diaphragmatic hernia
    • Thorax / lungs
    • Gastrointestinal
    • Genitourinary
    • Abdominal wall
    • Skeleton
    • Tumors
    • Multiple defects
    • Umbilical cord
  • Genetic syndrome
  • Placental problems
    • Previa / accreta
    • Molar
    • Other
  • Oligo / polyhydramnios
  • Miscarriage
  • Termination of pregnancy
  • Postmortem examination
  • Perinatal death
  • PE - FGR
  • Macrosomia
  • Labour - delivery
  • Preterm birth
  • Multiple pregnancies
    • TTTS / sFGR
    • TAPS
    • TRAP sequence
    • Conjoint twins
    • Other
  • Maternal disease
    • Cholestasis
    • Diabetes / obesity
    • Infections
    • Hyperemesis
    • Thromboembolism
    • Other
  • Ectopic pregnancy
  • Gyne / infertility
  • Miscellaneous

PE - FGR

  1. Prediction and prevention of early onset pre-eclampsia: The impact of aspirin after first trimester screening. View pdf
  2. FGR: Metabolic and cardiovascular profile at 3-4 years View pdf
  3. Maternal blood pressure throughout gestation and the risk of delivering a small-for-gestational-age neonate View pdf
  4. Assessement of placental perfusion in the preeclampsia L-NAME rat model with high-field DCE MRI View pdf
  5. Combination of maternal risk factors and first trimester biomarkers for prediction of early preeclampsia View pdf
  6. Prediagnostics of preeclampsia - differences between preeclampsia and other pathologies View pdf
  7. Expectant management of severe preeclampsia before 34 weeks of gestation View pdf
  8. Contribution of ductus venosus doppler in the management of intrauterine growth retardation View pdf
  9. Pregnancy outcome among women with low first trimester PAPP-A levels View pdf
  10. First trimester PAPP-A and β-hCG in the prediction of adverse pregnancy outcome: A Tunisian study View pdf
  11. Combination of Doppler and biophysical parameters for the prediction of acidemia in preterm FGR View pdf
  12. A potential role of circulating LHCGR forms for the prediction of preeclampsia in the first trimester of pregnancy View pdf
  13. First trimester screening for early and late preeclampsia based on maternal characteristics and biomarkers View pdf
  14. Effect of postnatal diet on reverting cardiovascular remodeling in fetal growth restriction View pdf
  15. Differential effect of intrauterine growth restriction and assisted reproductive technologies on fetal cardiovascular remodeling View pdf
  16. Differences in fetal brain metabolism assessed by MR spectroscopy in different clinical forms of late onset FGR View pdf
  17. Fetal brain cortical and corpus callosum assessed by MRI: prediction of neurodevelopment at 2 years in term SGA View pdf
  18. A case of severe gingival bleeding in a patient with preeclampsia View pdf
  19. Validation of sFlt-1/PlGF ratio curves for Mexican population. View pdf
  20. Correlation between intrauterine growth restriction and fetal arterial carboxyhemoglobin levels View pdf
  21. Neurosonographic assessment of the corpus callosum: biomarker of abnormal neurodevelopment in FGR View pdf
  22. Clinical evaluation of the ratio sFlt-1 /PlGF in a cohort of 20 to 34 weeks pregnant women in Greece: a pilot study View pdf
  23. Uterine and umbilical artery Dopplers at 28 weeks after a pathological uterine artery Doppler in the mid trimester View pdf
  24. Three years review of intrauterine growth restricted babies, management and outcome View pdf
  25. Two interesting cases of unusual presentation of severe PET, challenge and dilemma in diagnosis and management View pdf
  26. External validity of first trimester algorithms in the prediction of pre-eclampsia disease severity View pdf
  27. First trimester prediction of preeclampsia: external validity of algorithms in a prospectively enrolled cohort View pdf
  28. Comparison of placental resistin expression in pregnancies complicated by preeclampsia and fetal growth restriction View pdf
  29. Maternal factors influencing gestational age and birth weight of newborns View pdf
  30. First trimester metabolic profile: An independent predictor of pre-eclampsia View pdf
  31. Preeclampsia: Prevalence and perinatal complications View pdf
  32. Prediction of the birth weight based on the abdominal circumference at the first trimester screening View pdf
  33. Placenta related complications at term in pregnancies with increased 2nd trimester uterine artery PI View pdf
  34. Placental growth factor levels relationship to clinical course and possible risk prediction of preeclampsia View pdf
  35. Integrating sequential screening for placental dysfunction in the first and second trimester in a cohort of 506 low-risk patients View pdf
  36. Expression of soluble VEGF receptor-1 and PLGF in FGR and the intervention mechanism of tetramethylpyrazine View pdf
  37. Does a small for gestational age umbilical cord diameter predict fetal growth restriction View pdf
  38. An unusual case of severe IUGR ? Genetic cause View pdf
  39. Soluble receptor fms-like tyrosine kinase-1 testing: analytical performances of the new B•R•A•H•M•S sFlt-1 KRYPTOR View pdf
  40. Biomarkers of oxidative stress and the assessment of uterine perfusion – early detection of preeclampsia View pdf
  41. Impact of umbilical artery and middle cerebral artery Doppler to predict unfavorable outcome in a cohort of severe IUGR View pdf
  42. Correlation of pro and anti inflamatory cytokines in different grades of pre-eclampsia View pdf
  43. Haematologic parameters to predict SGA and/or oligohydramnios View pdf
  44. Ultrasound sonographic prediction of fetal lung maturity in preeclaptic and diabetic patients View pdf
  45. Catastrophic outcome of a HELLP syndrome View pdf
  46. Assessment of normal materno-fetal circulation using umbilical and uterine artery pulsatility index View pdf
  47. First trimester MAP and uterine artery PI in singelton versus twin pregnancies with and without pre-eclampsia View pdf
  48. Predictors of neonatal morbidity in pregnancies with antenatal HELLP syndrome View pdf
  49. The effects of leptin and progesterone on the BeWo cell invasion View pdf
  50. Comparison of serum leptin levels in pregnant women with PE and those with normal blood pressure View pdf
  51. Low birth weight (<2500 gram) at late preterm and term – is it about birth weight percentile or gestational age? View pdf
  52. Does placenta location have an effect on the accuracy of sonographic estimated fetal weight at term? View pdf
  53. A case of a partially hydatidiform mole complicated by pre-eclampsia View pdf
  54. P-wave dispersion in preeclampsia View pdf
  55. The value of middle cerebral artery and umbilical doppler indices in assessment of fetal wellbeing & prediction of neonatal outcome in IUGR and PE View pdf
  56. Assessment of placental volume and vascularization by 3D power Doppler ultrasound at 11-14 weeks View pdf
  57. The association between second trimester unexplained maternal seum AFP levels (≥2 mom) and pregnancy complications View pdf
  58. The expressions of CD200 and CD200R molecules on myeloid and lymphoid dendritic cells in pre-eclampsia and normal pregnancy View pdf
  59. The predominance of Th17 lymphocytes and decreased number and function of Treg cells are present in preeclampsia. View pdf
  60. Clinicopathologic parallels in the fetoplacental insufficiency diagnostics View pdf
  61. First trimester prediction of preeclampsia using neutrophil / lymphocyte ratio and platelet / lymphocyte ratio View pdf
5835755725665625405325315225175165155145045035024904894764674313973963943923883873843623523333253203173152852772742732692622602572502211881841341211079064462726251410953
© 2014 The Fetal Medicine Foundation